Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Articles by Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Latest Updated Articles
- Study Summary: Cardiovascular Safety Profile of Carfilzomib in Multiple Myeloma Clinical Trials
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
3
FDA Approves Rucaparib in BRCA-Mutated mCRPC
4
Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization
5
